Nadine Blanco

Mrs. Nadine Blanco

Instituto Maimónides de Investigación Biomédica de Córdoba, Cordova, Spain
+1
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2022 in Toxins
Verified
Journal Article
Open access
PDF file
ANAna Navas
Ana Navas
Berta Ruiz-LeónBerta Ruiz-León
Berta Ruiz-León
PSPilar Serrano
Pilar Serrano
MAManuel Martí Antonio
Manuel Martí Antonio
MEM Luisa Espinazo
M Luisa Espinazo
Carmen Moreno-AguilarCarmen Moreno-Aguilar
Carmen Moreno-Aguilar
Inducing tolerance in Hymenoptera-allergic patients, bee venom immunotherapy (BVIT) is a widely accepted method to treat severe allergy to bee stings. In order to increase the existing knowledge on the underlying immunological mechanisms and look for possible biomarkers predictive of efficacy, a group of 20 bee-venom-allergic patients (AG) were thoroughly examined during their first year of BVIT. In addition, the results of treated patients with those of an untreated group of 20 tolerant beekeepers (TG) who had previously shown a firm suppressor-regulatory profile were compared. Tolerance in AG patients was invariably associated with a significant regulatory response characterised by the expansion of Helios− subpopulation and increased IL-10, specific IgG4 (sIgG4), and kynurenine levels. Although specific IgE (sIgE) levels increased transiently, surprisingly, the T helper type 2 (Th2) population and IL-4 levels rose significantly after one year of immunotherapy. Thus, the picture of two parallel phenomena emerges: a tolerogenic response and an allergenic one. Comparing these results with those obtained from the TG, different immunological mechanisms appear to govern natural and acquired tolerance to immunotherapy. Of particular interest, the kynurenine levels and T regulatory (Treg) Helios− population could be proposed as new biomarkers of response to BVIT.

27 August 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
PÁPaula Álvarez-Romero
Paula Álvarez-Romero
RARocio Aguado
Rocio Aguado
JMJuan Molina
Juan Molina
ATAntonio Trujillo-Aguilera
Antonio Trujillo-Aguilera
MVMayte Villalba
Mayte Villalba
Aurora Jurado RogerAurora Jurado Roger
Aurora Jurado Roger
Background: Cross-reactivity between nonspecific lipid transfer proteins could cause anaphylaxis, further influencing food avoidance and nutrient deficiencies. The one affecting olive pollen (Ole e 7) and peach (Pru p 3) may underlie a variety of pollen-food syndromes, though a deep molecular analysis is necessary. Methods: Three Ole e 7-monosensitised patients (MON_OLE), three Pru p 3-monosensitised patients (MON_PRU) and three bisensitised patients (BI) were selected. For epitope mapping, both digested proteins were incubated with patient sera, and the captured IgE-bound peptides were characterised by LC-MS. Results: The analysis revealed two Ole e 7 epitopes and the three Pru p 3 epitopes previously described. Interestingly, the “KSALALVGNKV” Ole e 7 peptide was recognised by MON_OLE, BI and MON_PRU patients. Conversely, all patients recognised the “ISASTNCATVK” Pru p 3 peptide. Although complete sequence alignment between both proteins revealed 32.6% identity, local alignment considering seven residue fragments showed 50 and 57% identity when comparing “ISASTNCATVK” with Ole e 7 and “KSALALVGNKV” with Pru p 3. Conclusions: This study mapped sIgE-Ole e 7-binding epitopes, paving the way for more precise diagnostic tools. Assuming non-significant sequence similarity, structural homology and shared key residues may underlie the potential cross-reactivity between Ole e 7 and Pru p 3 nsLTPs.

2 December 2024
Verified
Preprint
Open access
PDF file
TATeresa Alfaya
Teresa Alfaya
AVArantza Vega
Arantza Vega
LMLluìs Marqués
Lluìs Marqués
JIJesús Macías Iglesias
Jesús Macías Iglesias
JGJavier Pereira González
Javier Pereira González
BRBerta Ruiz
Berta Ruiz
Background The sting challenge test (SCT) is regarded as the most reliable method for assessing the effectiveness of venom immunotherapy (VIT). However, its predictive value in patients undergoing VIT is still unclear. This study aims to evaluate the predictive value of the SCT. Methods A multicenter retrospective observational study was conducted on patients receiving VIT who underwent SCT. The study gathered data on patient demographics, diagnosis, immunotherapy details, outcomes of the SCT and their comparison to subsequent field sting (FS) results. Results A total of 261 patients were included, and 372 SCT were recorded. The majority of the patients (75.1%) were men. A diagnosis of mastocytosis was confirmed in 7.7%. The final diagnoses were allergy to Apis mellifera (48.7%), Polistes dominula (36.8%), Vespula spp. (2.7%) and Polistes dominula plus Vespula spp. (10,7%). Sting challenge tests were performed with Apis in 61.6% of the overall tests, Polistes in 34.1% and Vespula in 4.3%. The majority (95.7%) of the SCT were negative. Regarding FS, 146 patients (56.2%) experienced 306 FS of which 95.1% were negative. Among these 146 patients, 137 had a negative SCT, and 130 of these also had a subsequent negative FS, resulting in a 94.9% of negative predictive value (NPV) of the test. Of the patients who experienced FS, 9 had a positive SCT and only 3 of them had a positive FS, resulting in a positive predictive value of 33,3%. Conclusions SCT is a safe procedure, and its high NPV emphasizes the usefulness of this test in assessing the effectiveness of VIT.